In pediatric cases of ATLL (2–18 years old), frequency of deletion of the CDKN2A locus or mutation of p53 was found in five of the eight patients, suggesting that alteration in these genes is associated with a more rapid progression of ATLL [56]. This evidence concerns the gene TP53 and adult T-cell leukemia/lymphoma.